277 related articles for article (PubMed ID: 33114404)
21. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut.
Underwood MA; German JB; Lebrilla CB; Mills DA
Pediatr Res; 2015 Jan; 77(1-2):229-35. PubMed ID: 25303277
[TBL] [Abstract][Full Text] [Related]
22. Conditioned medium from Bifidobacteria infantis protects against Cronobacter sakazakii-induced intestinal inflammation in newborn mice.
Weng M; Ganguli K; Zhu W; Shi HN; Walker WA
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G779-87. PubMed ID: 24627567
[TBL] [Abstract][Full Text] [Related]
23. Synbiotic supplementation containing Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis.
Sheng K; He S; Sun M; Zhang G; Kong X; Wang J; Wang Y
Food Funct; 2020 May; 11(5):3964-3974. PubMed ID: 32400787
[TBL] [Abstract][Full Text] [Related]
24. In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.
Valdés-Varela L; Ruas-Madiedo P; Gueimonde M
Int J Food Microbiol; 2017 Feb; 242():19-23. PubMed ID: 27866040
[TBL] [Abstract][Full Text] [Related]
25. Arabinoxylan-based substrate preferences and predicted metabolic properties of Bifidobacterium longum subspecies as a basis to design differential media.
Calvete-Torre I; Sabater C; Delgado S; Ruas-Madiedo P; Rupérez-García A; Montilla A; Javier Moreno F; Margolles A; Ruiz L
Food Res Int; 2023 May; 167():112711. PubMed ID: 37087214
[TBL] [Abstract][Full Text] [Related]
26. Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense.
Bunesova V; Lacroix C; Schwab C
BMC Microbiol; 2016 Oct; 16(1):248. PubMed ID: 27782805
[TBL] [Abstract][Full Text] [Related]
27.
Quinn EM; Slattery H; Walsh D; Joshi L; Hickey RM
Foods; 2020 Mar; 9(3):. PubMed ID: 32192119
[TBL] [Abstract][Full Text] [Related]
28. Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial.
Smilowitz JT; Moya J; Breck MA; Cook C; Fineberg A; Angkustsiri K; Underwood MA
BMC Pediatr; 2017 May; 17(1):133. PubMed ID: 28558732
[TBL] [Abstract][Full Text] [Related]
29. Comparative Genome Analysis of
Duar RM; Casaburi G; Mitchell RD; Scofield LNC; Ortega Ramirez CA; Barile D; Henrick BM; Frese SA
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114073
[TBL] [Abstract][Full Text] [Related]
30. In-Vitro Growth Inhibition of Bacterial Pathogens by Probiotics and a Synbiotic: Product Composition Matters.
Piatek J; Krauss H; Ciechelska-Rybarczyk A; Bernatek M; Wojtyla-Buciora P; Sommermeyer H
Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32403297
[TBL] [Abstract][Full Text] [Related]
31.
Ding M; Li B; Chen H; Ross RP; Stanton C; Zhao J; Chen W; Yang B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674840
[TBL] [Abstract][Full Text] [Related]
32. Prebiotics as excipients for enhancement of stability and functionality of
Basholli-Salihu M; Kryeziu TL; Nebija D; Salar-Behzadi S; Viernstein H; Mueller M
Pharmazie; 2019 Jun; 74(6):326-333. PubMed ID: 31138368
[No Abstract] [Full Text] [Related]
33. Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial.
Awasthi S; Wilken R; Patel F; German JB; Mills DA; Lebrilla CB; Kim K; Freeman SL; Smilowitz JT; Armstrong AW; Maverakis E
Trials; 2016 Jul; 17(1):340. PubMed ID: 27449926
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010.
Serafini F; Strati F; Ruas-Madiedo P; Turroni F; Foroni E; Duranti S; Milano F; Perotti A; Viappiani A; Guglielmetti S; Buschini A; Margolles A; van Sinderen D; Ventura M
Anaerobe; 2013 Jun; 21():9-17. PubMed ID: 23523946
[TBL] [Abstract][Full Text] [Related]
35. Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics.
Button JE; Autran CA; Reens AL; Cosetta CM; Smriga S; Ericson M; Pierce JV; Cook DN; Lee ML; Sun AK; Alousi AM; Koh AY; Rechtman DJ; Jenq RR; McKenzie GJ
Cell Host Microbe; 2022 May; 30(5):712-725.e7. PubMed ID: 35504279
[TBL] [Abstract][Full Text] [Related]
36. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile.
Kondepudi KK; Ambalam P; Nilsson I; Wadström T; Ljungh A
Anaerobe; 2012 Oct; 18(5):489-97. PubMed ID: 22940065
[TBL] [Abstract][Full Text] [Related]
37. Effects of dietary prebiotics, probiotic and synbiotics on performance, caecal bacterial populations and caecal fermentation concentrations of broiler chickens.
Mookiah S; Sieo CC; Ramasamy K; Abdullah N; Ho YW
J Sci Food Agric; 2014 Jan; 94(2):341-8. PubMed ID: 24037967
[TBL] [Abstract][Full Text] [Related]
38. Structure and Function of Bovine Whey Derived Oligosaccharides Showing Synbiotic Epithelial Barrier Protective Properties.
Duncan PI; Aitio O; Heiskanen A; Niemelä R; Saarinen J; Helin J; Porta N; Fiaux M; Moënnoz D; Golliard M; Cherbut C; Berrocal R; Austin S; Sprenger N
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32640639
[TBL] [Abstract][Full Text] [Related]
39. Selective Utilization of the Human Milk Oligosaccharides 2'-Fucosyllactose, 3-Fucosyllactose, and Difucosyllactose by Various Probiotic and Pathogenic Bacteria.
Salli K; Hirvonen J; Siitonen J; Ahonen I; Anglenius H; Maukonen J
J Agric Food Chem; 2021 Jan; 69(1):170-182. PubMed ID: 33382612
[TBL] [Abstract][Full Text] [Related]
40. Utilization of diverse oligosaccharides for growth by Bifidobacterium and Lactobacillus species and their in vitro co-cultivation characteristics.
Dong Y; Han M; Fei T; Liu H; Gai Z
Int Microbiol; 2024 Jun; 27(3):941-952. PubMed ID: 37946011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
